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Analytical techniques used for multivariate analysis of endogenous metabolites in biological
systems (e.g., metabolomics, metabonomics) must be capable of accurately and selectively
monitoring many known and unknown molecules that span a diverse chemical spectrum and
over extremely large dynamic concentration ranges. Mass spectrometric (MS) and electro-
chemical array (EC-Array) detection have been widely used for multi-component analysis with
applicability to low-level (fmol) metabolites. Described here are practical considerations and
results obtained with the combined use of EC-Array and MS for HPLC-based multivariate
metabolomic analysis. Data presented include the study of changes in rat urinary metabolite
profiles associated with xenobiotic toxin exposure analyzed by HPLC using water:acetonitrile
binary gradient conditions and post-column flow splitting between EC-Array and MS
detectors. Results show complementary quantitative and qualitative analysis and the ability to
differentiate sample groups consistent with xenobiotic-induced histopathological changes. The
potential applicability of this hyphenated technique for biomarker elucidation through
measurement of redox active compounds that are commonly associated with disease pathol-
ogy and xenobiotic toxicity is discussed. The use of EC reactor cells in series with MS is also
presented as a means of producing likely metabolites to facilitate structural elucidation and
confirmation. (J Am Soc Mass Spectrom 2004, 15, 1717–1726) © 2004 American Society for
Mass SpectrometryThe metabolome can be defined as the entirecellular complement of endogenous low molecu-lar weight (typically 1000 Da) biomolecules [1].
Metabolomics research is commonly performed in the
context of systems biology [2], which involves inte-
grated study of the genome, transcriptome, proteome,
and metabolome. These investigations, typically con-
ducted in plants [3] and individual cells or cell types [4],
are often geared toward understanding metabolic reg-
ulation (i.e., homeostasis) and fluxes associated with a
given genetic, physiological, or developmental state. A
similar term, metabonomics [5], more typically refers to
analysis of dynamic changes in metabolite profiles in
higher organisms, which have a high degree of biomo-
lecular compartmentalization. In this context, endoge-
nous metabolic profiles, typically measured in animal
tissue or bio-fluids, are often viewed as fingerprints that
are reflective of highly complex anatomically and spa-
tially integrated metabolic networks. In practice, the
distinction between metabolomics and metabonomics is
not always clear, and, as is common, these terms will be
used interchangeably within this text. Regardless of
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in biological systems is an important aspect of studies
that are aimed toward further understanding complex
processes such as those associated with aging and
development [6, 7], disease [8], drug efficacy [9], and
xenobiotic toxicity [10, 11]. Metabolomics is viewed as
holding great promise, for example, in specific biomar-
ker discovery for clinical diagnostics, drug discovery,
and development.
The metabolome includes, but is not limited to,
amino acids, carbohydrates, lipids, peptides, purines,
pyrimidines, vitamins, and numerous metabolites in-
volved in biosynthesis and biodegradation pathways
and serving various functions [e.g., antioxidants, cofac-
tors, intra- and intercellular regulatory and signaling
molecules (i.e., hormones, enzyme inhibitors, neuro-
transmitters, etc.)]. Bioanalytical techniques used for
metabolomics should thus be capable of accurately
monitoring numerous known and unknown molecules
that span a diverse chemical spectrum and large dy-
namic concentration range. Biological variability and
environmental factors such as the presence of foreign
compounds (e.g., dietary, exposure, therapeutics), their
metabolites, and systemic interactions further challenge
metabolomics research. Also, the distinction between
homeostatically controlled and foreign molecules is
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tibly related to homeostasis (e.g., resulting from non-
enzymatic processes) may frequently provide the most
useful insight to an organism’s response to a given
perturbation (e.g., markers of oxidative stress [12–14]).
Several analytical techniques are useful for metabo-
lomics including gas chromatography with mass spec-
trometry (GC-MS) [15, 16], liquid chromatography with
coulometric array electrochemistry [17–21] (LC-EC-
Array), LC-MS [22–24], and nuclear magnetic resonance
spectroscopy (NMR) [5, 8, 10, 25]. The qualitative char-
acteristics of techniques, such as MS and NMR, provide
essential data for chromatographic peak identification
and purity, structural elucidation, and for normalizing
multivariate data. While NMR allows the study of any
molecule that contains an active nuclide (e.g., 1H and
13C), it is generally limited to detection and analysis of
highly abundant metabolites (typically g quantities).
MS data obtained with and without fragmentation of
individual metabolites and accurate mass measure-
ments with high-resolution instruments are key advan-
tages to LC-MS based metabolomics research. MS tech-
niques are very sensitive and versatile but the choice of
ionization technique, mass analyzer, acquisition mode,
and instrumental parameters for a given analysis is very
dependent on experimental goals, which may range
from purely qualitative and exploratory to quantitative
and specifically targeted. LC-EC-Array has been previ-
ously used for multivariate profiling of endogenous
metabolites with reported detection of several hundred
metabolites in a single analysis [18], fmol limits of
detection and greater than four orders of magnitude
dynamic range [17, 21]. The applicability of LC-EC-
Array to redox active species (e.g., hormones, neuro-
transmitters, anti-oxidants, markers of oxidative stress)
has led to its widespread use to study oxidative metab-
olism and redox biochemical processes, including those
related to aging [26, 27], immune response [28], inflam-
mation [29, 30], and many pathological processes
[30–34]. However, EC-Array detection is limited to
so-called “redox active” compounds (i.e., species easily
capable of undergoing oxidative or reductive reactions)
and, although useful qualitative (viz., voltammetric)
data is obtained, its utility for structural elucidation is
limited. Recognizing that no single technique can be
expected to meet all of the field’s diverse challenges,
many metabolomics research programs employ several
complementary analytical techniques.
Described below are two general approaches that
utilize EC in combination with MS for metabolomics
research, parallel EC-Array-MS for LC-based multivar-
iate analysis and serial EC-MS to generate and study
metabolites. The use of parallel detection for explor-
atory multivariate profiling is exemplified by studies of
xenobiotic toxin exposure in animals with an overall
focus on complementary analysis with regard to chem-
ical scope, dynamic range, resolving capacity, and qual-
itative information obtained. To our knowledge, this is
the first report of parallel EC-Array-MS detection.The use of decoupled EC flow cells in series with MS
ion sources has been previously described [35] and is
further presented in articles within this issue. Of par-
ticular relevance to metabolomics is the use of on-line
EC reactions to produce likely metabolites using known
metabolites as reactants [36, 37]. Redox reactions con-
ducted in combination with analytical and preparative
scale separations and qualitative techniques such as MS
or NMR may be a useful route to isolation of sufficient
quantities for structural elucidation and confirmation.
Presented are our initial investigations of the use of
serial EC-MS for identification of potential metabolites
observed in biological samples.
Experimental
Chemicals
All solvents were HPLC grade or better. Formic acid
was obtained from EM Science (Gibbstown, NJ). Am-
monium formate and ammonium acetate were Fluka
brand from Sigma-Aldrich (St. Louis, Mo). Chemicals
were high purity and used without further purification.
Instrumentation and Software
In our basic investigations of coupling EC in series and
parallel with various MS instruments we found that the
general considerations (e.g., mobile phase, fluidic, elec-
trical, data acquisition), discussed below, were common
among devices and were primarily a function of the
ionization conditions. Since a variety of MS technolo-
gies are needed to address the many aspects of metabo-
lomics research, we present data from single quadru-
pole MS (1100 MSD, Agilent Technologies, Palo Alto,
CA) with electrospray (ESI) and atmospheric pressure
chemical ionization (APCI) as a basic representation of
this hyphenated EC-MS approach.
A Model 5021 EC cell (ESA Inc., Chelmsford, MA)
was used for serial EC-MS configurations. For parallel
detection, an EC-Array detector (CoulArray, ESA Inc.)
was used with up to 16 serial coulometric cells main-
tained at individual constant potentials (all reported
potentials are vs. Pd quasi-reference electrode). Figure 1
illustrates both serial and parallel EC/MS configura-
tions used. Data acquisition with Agilent ChemStation
and ESA CoulArray software was synchronized using a
contact closure. Pirouette (Infometrix, Inc., Woodinville,
WA) was used for post-acquisition exploratory chemo-
metric analysis.
Analytical Conditions
Data presented are based on reversed-phase HPLCwith
water:acetonitrile binary gradient and various condi-
tions (e.g., flow rate, column, gradient profiles) and
analytical run times of 6 to 15 min. Supporting electro-
lytes were premixed in each mobile phase to provide
sufficient conductivity for EC-Array detection and to
d for
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Agilent 1100 or ESA LC system was used for solvent
and sample delivery. Post-column flow was split be-
tween EC and MS detectors with split ratios optimized
for MS performance. Specific conditions are described
with results.
Biological Samples
Samples from studies of acute exposure of animals to
xenobiotic compounds were kindly provided by Dr.
Timothy Maher (Mass College of Pharmacy, Boston,
Massachusetts) and by Dr. Elaine Holmes (Imperial
College, London). In one study, six groups (n  5 per
group) of adult male Sprague-Dawley rats, receiving
Purina 5001 rodent laboratory chow and water ad
libitum, received single oral doses of acetaminophen
(20, 200, or 300 mg/kg), acetylsalicylic acid (200 mg/kg)
or vehicle. Urine was collected for the first 8 h. and
subsequent 24 h periods and diluted 10-fold in water
prior to analysis. In a second study, adult male Fisher
344 rats were administered single intraperitoneal doses
of maleic acid (300 mg/kg), chloroethanamine (750
mg/kg) or vehicle. Histopathological data showed
maximal renal cortical and renal papillary toxic re-
sponse in animals in the second day after receiving
maleic acid and chloroethanamine, respectively, with
complete recovery by the fifth day. Urine was collected
over 24 h periods and samples from Day 2 and Day 5
were diluted 10-fold in water prior to analysis. Further
details of the animal experimental protocols are de-
scribed elsewhere [10, 38].
Practical Considerations for Parallel and Serial
EC-MS
The described EC cells utilize three electrodes (refer-
ence, working, and auxiliary) for controlled-potential
amperometry and require a minimum level of solu-
tion (i.e., mobile phase) conductivity for optimal
functioning of the potentiostatic circuit. Commonly
used additives for LC-MS [e.g., 0.1% (23.6 mM)
formic acid or 10 mM ammonium acetate)] are often
inadequate for LC-EC detection as they lead to low
Figure 1. Diagram of analytical EC/MS syste
*Pre-column cell was only present when requireresponse and peak tailing. In our investigations, anoptimal EC response was obtained with, for example,
20 mM ammonium acetate or formate buffer (10 mM
ammonium formate:50 mM formic acid) with no
significant adverse effects on MS detection (e.g.,
ionization suppression, adduct formation, back-
ground noise). Adding supporting electrolyte after
the flow split may be an alternative approach partic-
ularly when incorporating EC-Array detection capa-
bilities to an established LC-MS method.
MS ion source emitters used at high voltage, such as
ESI, can lead to current flow through a conductive fluid,
which may affect the interfacial potential of distal,
upstream, wetted components (e.g., injector and analyt-
ical column). Since this can lead to uncontrolled redox
reactions, thereby compromising analyte integrity [39],
a stainless steel fluidic union was connected to the
ground of the ion source/interface high voltage power
supply as previously described [35].
Based on volume and pressure considerations, the
flow rates used with EC-Array detection are typically
between 0.25 to 2.0 mL/min. For parallel EC-Array and
MS detection, passive flow splitting was used with flow
ratios optimized for the specific MS interface used and
to remain within the above flow rate range for the EC
cells.
EC-Array Detection
The general concepts of EC-Array detection are de-
scribed in detail elsewhere [17, 20, 21]. Briefly, this
technique employs up to 16 series EC cells with porous
graphitic carbon-based working electrodes (WE). Each
cell is typically poised at a different potential, thereby
spanning a wide potential window to allow detection of
a wide scope of redox active metabolites. Efficient
electrolysis obtained with high surface area WE allows
selective detection and resolution of co-eluting analytes
based on differences in their relative ease of oxidation
and/or reduction. Hydrodynamic voltammograms
(HDV) for each redox active metabolite are obtained
from the response across adjacent EC-Array sensors.
These data are a reflection of the kinetic and thermody-
namic components of electron transfer (ET) reactions
owing both parallel and serial configurations.
on-line reaction of pure metabolite compounds.m shwith demonstrated use for peak identification and peak
, scan
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(fmol) metabolites [17].
Results and Discussion
The following data, although from different experi-
ments, are described within the context of an overall
scheme that progresses from exploratory to targeted
analysis. This includes: (1) generating HPLC EC-
Array-MS multivariate fingerprints with rapid LC
methods; (2) investigating the presence of natural sam-
ple groupings based on exploratory chemometric anal-
ysis; and (3) interrogating stored EC and MS data to
characterize metabolite peaks, or peak patterns, that
significantly contribute to interesting sample group-
ings. The initial use of rapid methods is geared for
medium throughput (6 to 15 min run times) with some
tolerance for chromatographically unresolved peaks.
The results from these exploratory studies are used to
Figure 2. MS base peak chromatogram (top) a
channels shown for clarity). MS chromatogram
20 L injection of 10-fold diluted urine. Gradien
ammonium formate and 50 mM formic acid; flow
mm i.d. column; 4:1 passive post-column flo
potentials 0 to 1050 mV in increments of 70
fragmentor voltage 70 V scan range m/z 50–850guide further analysis of stored data and, when appro-priate, more targeted instrumental analysis for quanti-
tation, structural elucidation and for further character-
izing interesting metabolite patterns. Serial EC may
then be used to produce possible metabolites to aid in
structural confirmation. We have found this approach
to be one way of efficiently and effectively using the
described analytical tools to study complex biological
processes and toward biomarker discovery.
Xenobiotic Toxicity Studies
A representative chromatogram of rat urine analyzed
by parallel EC-Array-MS is shown in Figure 2. As
expected, the MS ion chromatogram shows relatively
few directly visible metabolite peaks. Mass spectral
data from full scan exploratory metabonomic studies
are typically processed by extracting discrete signals
each defined by a particular retention time and m/z, and
using algorithms to help distinguish analytical signal
C-Array multi-channel chromatogram (11 of 16
eled with base peak m/z. Analytical conditions:
ion 1 to 100% aqueous acetonitrile with 10 mM
1.5 mL/min; Shiseido C18, 3 m, 75 mm  4.6
lit to EC-Array: MS, respectively. EC-Array
ESI positive mode, capillary voltage 3500 V,
speed 1.2 s/cycle.nd E
is lab
t elut
rate
w sp
mV.from background noise [23]. The resulting data, often
, folic
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typically processed by chemometric techniques. Chro-
matographic variability, ionization suppression, adduct
formation, and in-source oxidation with MS and elec-
trode adsorptive and other non-Faradaic processes with
EC are important factors to consider in these multivar-
iate analyses. Our data show that the concurrent acqui-
sition of EC-Array and MS data for each metabolite
peak helps to address these potential issues. For exam-
ple, the observation of a particular redox active metab-
olite peak (Figure 2) allows the analyst to conduct a
more informed and targeted interrogation of corre-
sponding MS data. Likewise, specific MS data are
useful to normalize for retention time variability ob-
served with both MS and EC-Array data.
The EC-Array multi-channel chromatogram in
Figure 2 is shown at 5 amperes full scale to illustrate
the most abundant redox active metabolites. This scale
is approximately a factor of 103 above the average
baseline noise. Using CoulArray software algorithms
set for detection of peaks with signal greater than 10
times the baseline noise, an average of 168  34 distinct
redox active species (peak clusters) were detected in rat
urine samples (n  22 inclusive of several treatment
groups) within a 12 min chromatographic run time. The
detection scope of EC-Array includes compounds with
chemical substituents such as aryl alcohols, aryl amines,
secondary and tertiary aliphatic amines, sulfides, and
conjugated dienes. Table 1 is a brief list of redox active
chemical or metabolite classes for which EC-Array has
been used for targeted quantitative bioanalysis. It
should be noted that metabolites not detected by EC-
Array include many carbohydrates, lipids, amino acids,
and peptides that lack these redox active substituents.
However, considering that there are tens to hundreds of
known endogenous metabolites with the above redox
active substituents, exploratory analysis with high sen-
sitivity detection typically results in information-rich
profiles as seen in these and other studies [18].
With the described conditions, relatively few ana-
lytes responded on both MS and EC-Array detectors.
This may, in part, be attributed to the expected low
Table 1. Representative metabolites detectable by EC-Array
Chemical structure or
metabolite class
Amino acids, related peptides Cyste
Aryl amine Kynur
Biogenic amine Dopa
Chroman -, -
Hormone and metabolite Estrog
Conjugated polyenes Carot
Pterin and Pteridine Tetrah
Purines Guan
Pyridine Pyrido
Quinone/hydroquinone Coenz
Sulfide Gluta
Vitamin A, B6sensitivity of quadrupole-based exploratory m/z scan-ning. In addition, our results indicate that many redox
active urinary metabolites exist as solution phase neu-
tral species under a variety of reversed-phase chro-
matographic conditions. For example, peaks annotated
in Figure 2 are ascorbic acid (AA), uric acid (UA),
5-hydroxyindoleacetic acid (5HIAA) and homovanillic
acid (HVA). Of these metabolites, only uric acid was
detected from extracted ion chromatograms (above
baseline noise) as its protonated or adducted molecule
[e.g., M  X (X  Na, K, NH4
)]. It should be noted
that since these analyses are, by design, non-targeted,
changing conditions to favor ionization of specific me-
tabolites (e.g., post-column addition of base for gas-
phase negative ion formation) is not a primary consid-
eration. The described orthogonal nature of EC and MS
detection was also observed when using alternate con-
ditions, including several combinations of ESI, APCI,
positive and negative ionization using neutral or acidic
mobile phase conditions, and even with targeted se-
lected ion monitoring (additional data not shown). The
combined detection scope of MS and EC-Array thus
provided higher coverage in a single analysis of the
wide dynamic range and broad chemical diversity of
urinary metabolites.
Based on external calibration standards, peaks evi-
dent in Figure 2, displayed at 5 A full scale, corre-
spond to approximately 2.0 to 40 ng on-column or 1 to
20 g per mL of urine. Figure 3 is an overlay of a single
EC detector channel (240 mV) for eight samples repre-
senting 20-fold lower metabolite levels. These signals
are due to pg quantities of analyte on column and are
consistent with reported 10 to 1000-fold lower limits of
detection obtained with EC-Array when compared to
photodiode array detection [19, 40].
Our studies have primarily utilized EC-Array data
for chemometric analyses and MS data primarily for
subsequent qualitative and confirmatory characteriza-
tion of specific interesting variables revealed. A Coul-
Array software utility was used to adjust for chromato-
graphic variability followed by conversion of otherwise
raw EC-Array data into a generic format (text file) for
pattern recognition analysis. This approach allowed
Examples
nkephalins, homocysteine, methionine, tryptophan, tyrosine
e, 3-hydroxykynurenine
, epinephrine, norepinephrine, serotonin
-Tocopherol, 5-nitro--tocopherol
thyroxines
s, retinoids, vitamin D
folate, tetrahydrobiopterin
=-deoxyguanosine, hypoxanthine, uric acid
pyridoxine
Q10, plastoquinone, vitamin K1
e, glutathione disulfide, homocysteine
acid, C, D, E, Kine, e
enin
mine
, -, 
ens,
enoid
ydro
ine, 2
xal,
yme
thionrapid data processing—typically 5 min for 100 sam-
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analysis.
Samples obtained from an NMR-based metabo-
nomic toxicity study were analyzed by LC-EC-Array-
MS. Histopathological data showed maximal renal
cortical and renal papillary toxic response in animals
in the second day after receiving MA (300 mg/kg)
and CE (750 mg/kg), respectively, with complete
recovery by the fifth day. A scores plot (Figure 4)
Figure 3. Overlay of amplified single channel chromatograms
from EC-Array detection of urinary metabolites from several
animals. Analytical conditions: 20 L volumes of 10-fold diluted
urine; binary gradient 1.0 to 80% aq. CH3CN (vol/vol) in 6 min,
with 2 min hold at 80% CH3CN and 2 min re-equilibration;
supporting electrolyte 20 mM ammonium acetate; flow rate 1.0
mL/min; Shiseido CapCell Pak C18 MG 3 m, 7.5 cm  4.6 mm
i.d. column; post-column flow split (4:1) EC: ESI-MS; EC-Array
potentials (0 to 840 mV in increments of 120mV).
Figure 4. PCA scores plot generated from EC-A
having evidence of toxin-induced renal histopat
and recovered animals (MA and CE Day 5). Analyticfrom principal components analysis (PCA) of EC-
Array data from these samples showed clear differ-
entiation between sample profiles obtained from MA
and CE treated animals (MA and CE Day 2) as
compared to controls and recovered animals (Day 5,
Figure 4). Also, a higher degree of variability was
found among controls when compared to pathologi-
cal or recovered animals. Repeated LC/EC/MS anal-
yses of these samples using several chromatographic
conditions resulted in very similar PCA results. These
results, including the relatively higher degree of
variability among controls, are in good qualitative
agreement with NMR-based metabonomic analysis of
these samples (personal communication, Dr. Elaine
Holmes, Imperial College, London).
PCA allows the reduction of highly complex data
into a smaller number of vectors that can be graphically
visualized to discern sample groupings. When sample
groupings correspond, in this case, to pathological
observations, eigenvector analysis can be used to dis-
cern which variables (peaks) contribute the most to a
given vector. Furthermore, when multiple correlated
metabolite peaks contribute significantly to a given
vector, this may provide information on the involve-
ment of whole or multiple pathways or specific pro-
cesses (e.g., immune response). In this approach we
have utilized EC-Array data to reveal these discrimina-
tor peaks or peak groupings with the intention to then
interrogate the associated MS data for qualitative infor-
data showing differentiation of sample groups
y (MA Day 2 and CE Day 2) from control (Ctrl)rray
hologal conditions as in Figure 2.
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to many aspects of metabolism, toxicity and disease
pathology, PCA of redox profiles in conjunction with
structurally informative MS data may provide useful
mechanistic insight.
In a model study of APAP-induced hepatotoxicity,
results from PCA of EC-Array data showed consistent
differentiation of high dose APAP (200 and 300 mg/kg,
0–8 h collection) from control, low dose (20 mg/kg)
APAP, and high dose (200 mg/kg) acetylsalicylic acid.
This differentiation was observed both exclusive and
inclusive of xenobiotic metabolite variables. From anal-
ysis of eigenvector loadings, possible endogenous
(E1-E4) marker peaks and xenobiotic metabolites (M1,
M3, M4) are shown in Figure 5.
These data further demonstrate the complemen-
tary nature of EC and MS detection. For example, MS
data, along with prior knowledge of a parent com-
pound’s analytical behavior and informed prediction
of biotransformations, was used to remove xenobiotic
data. This allowed more direct study of changes in
endogenous metabolite profiles by PCA. Also, EC-
Array data showed clear evidence of an APAP me-
tabolite that was not detected by MS (peak M1, Figure
5). Furthermore, MS data indicated that peak M3
consisted of two major components having m/z 313
and 232. These m/z values are consistent with the
commonly observed O-sulfated metabolite and the
less frequently observed mercapturic acid metabolite
of APAP, respectively. This is supported by EC-Array
voltammetric data where the putative O-sulfated
Figure 5. Overlay of EC-Array data from urine
mg/kg APAP (n  5 each group). Peaks label
labeled M indicate drug metabolites. Base peak m
are shown. APAP-M  S indicates coelution
Analytical conditions as in Figure 3.metabolite oxidized at a higher potential (840 mV)than parental APAP (600 mV), which can be expected
based on phenol substitution. Furthermore, the sim-
ilarity in voltammetric response between parental
APAP and the peak corresponding to m/z 232, sug-
gests that the easily oxidized -amidophenol group is
intact. These data are consistent with the commonly
observed ring thioether metabolites associated with
high-dose APAP. APAP-related hepatotoxicity is be-
lieved to be subsequent to CYP-450 oxidative meta-
bolic activation to form reactive quinoneimine spe-
cies with subsequent covalent binding, scavenger
glutathione (GSH) depletion and further metabolism
to APAP mercapturate [41]. Since APAP-mercaptur-
ate is a recognized marker of the so-called toxic
pathway of APAP, the described approach of explor-
atory multivariate analysis and targeted interroga-
tion of EC and MS data was an efficient and effective
way to determine relevant changes associated with
high dose APAP. These results demonstrate that the
combined use of EC-Array and MS provided useful
insight to these metabonomic toxicity studies by
expanding the scope of detection, selectivity and
qualitative information obtained in a single analysis.
On-Line EC Synthesis
The use of upstream decoupled EC flow cells in series
with MS has been previously described as a means of
synthesizing and characterizing likely drug metabolites
[36, 37, 42]. Our studies have also included the synthesis
of endogenous compounds using endogenous metabo-
ats administered (i.p.) vehicle, 20 mg/kg or 300
indicate endogenous metabolites while peaks
tios as determined from corresponding MS data
lfate and mercapturate metabolites of APAP.of r
ed E
/z ra
of sulite precursors [43]. EC reactions proceeded at specific
1724 GAMACHE ET AL. J Am Soc Mass Spectrom 2004, 15, 1717–1726potentials including aromatic hydroxylation of estra-
diol (E) at 1000 mV, O-dealkylation of 2- and 4-
methoxyestradiol (2ME and 4ME) at 600 mV, and
dehydrogenation of 2- and 4-hydroxyestradiol (2HE
and 4HE) at 300 mV. Furthermore, oxidation in the
presence of glutathione (GSH) showed evidence of
thioether conjugate formation at the same potentials as
above. For example, using analytical scale HPLC with
pre-column EC oxidation (Figure 1), ion chromato-
grams (Figure 6) suggest the EC formation of the
electrophilic estradiol-2, 3-quinone (2HEQ) and two
isomeric forms of 2,3-catecholestrogen-S-yl-glutathione
(2HE-SG). Our data indicate that the most abundant
ions produced from E, 2HE, 4HE, 2ME, and 4ME in the
presence of GSH all correspond to the reactive electro-
philic quinone and catecholestrogen glutathionyl con-
jugates (CE-SG). These results demonstrate that this
technique is capable of very closely simulating the
proposed biotransformation reactions related to estro-
gen-dependent carcinogenesis [44]. It must be recog-
nized that, when compared with enzymatic oxidation
(e.g., cytochrome P450), EC oxidation leads to the
formation of similar products for those enzymatic cat-
alyzed reactions that are supposed to proceed through
a mechanism initiated by a one-electron transfer oxida-
tion [36, 37]. Reactions initiated by hydrogen atom
abstraction such as hydroxylation of aromatic rings
without electron donating groups are generally not
mimicked by EC oxidation. Therefore, pre-column EC
can be used to produce some possible metabolites that
result from in vivo redox processes using the same
conditions as described for analysis of biological sam-
ples. Our approach is, therefore, to use analytical scale
EC-LC-MS to generate ng quantities of redox reaction
products from endogenous precursors for direct com-
parison of chromatographic, MS (e.g., MS/MS, MSn,
accurate mass) and EC voltammetric data between
EC-produced and biological metabolites. When EC
products correspond to unknown metabolite peaks,
initial structural information is gleaned from knowl-
edge of precursor, prediction of EC reactions, MS, and
Figure 6. Combined ion chromatograms from selected ion mon-
itoring of m/z values corresponding to protonated catechol (2HE,
m/z 289), quinone (2HEQ, m/z 287), and glutathionyl adduct
(2HE-SG, m/z 594) forms of estradiol. The dashed chromatogram
shows the unreacted 2,3-catechol, 2HE, with the pre-column EC
cell at 100 mV. The solid chromatogram shows the quantitative
conversion, at 500 mV, of 2HE to products whose m/z correspond
to the reactive quinone and isomeric forms of the mono-substi-
tuted glutathionyl adducts. Analytical conditions as in Figure 2.voltammetric data. Furthermore, recent studies havedemonstrated the feasibility of scaling up to produce
sufficient quantities for structural confirmation by
NMR [45]. The simplicity and speed of on-line EC-
LC-MS may thus provide an effective means of charac-
terizing some of the many unknown metabolites en-
countered in multivariate profiling of endogenous
metabolites.
Conclusions
EC-Array and MS were used for parallel HPLC detec-
tion by flow splitting, including supporting electrolyte
in the mobile phase and grounding the fluidic line
upstream of the MS inlet. The concurrent acquisition of
EC-Array and MS data showed several advantages in
exploratory multivariate profiling, including broader
coverage of the chemical diversity and concentration
range of endogenous metabolites. Furthermore, EC-
Array facilitated more targeted interrogation of corre-
sponding MS data. When combined, the qualitative
information from both techniques was useful for data
normalization, peak purity, and structural elucidation
studies. Results from several experiments were pre-
sented within the context of a general scheme that
involves multivariate profiling, exploratory chemomet-
rics, targeted analysis, and EC synthesis to aid in
structural elucidation. Chemometric analysis of raw
EC-Array profiles demonstrated the ability to differen-
tiate sample groups, consistent with xenobiotic-induced
histopathological changes. These results were repro-
ducible even when using different chromatographic
methods and were in agreement with NMR-based
metabonomic analyses. As many organic chemicals are
thought to exert toxicity via redox processes, the ac-
quired redox profiles may be particularly useful for
tissue and regio-specific modeling, diagnostic marker
identification, and mechanistic insight to xenobiotic-
induced toxicity.
The feasibility of electrochemically synthesizing en-
dogenous metabolites was demonstrated for estrogen
metabolites, including those proposed as potential
biomarkers of hormonal carcinogenesis. The simplicity
of forming reaction products on-line with LC-MS, using
the same conditions as biological sample analysis, pro-
vides a potentially efficient means of characterizing
some of the many unknown metabolites encountered in
metabolomics.
Ongoing studies include the use of EC-Array with
MS/MS and high resolution MS to assist with sub-
structural analysis, selectivity, scan sensitivity, and for
determination of elemental formula.
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